Short Bowel Syndrome Drugs Market Industry Analysis and Opportunity Assessment
The global healthcare landscape is witnessing a significant shift in the treatment of rare gastrointestinal disorders, and the Short Bowel Syndrome (SBS) Drugs Market is emerging as a key therapeutic segment. According to industry analysis, the market is projected to grow from US$ 1.38 billion in 2025 to US$ 2.87 billion by 2034, registering a CAGR of 8.44% from 2026 to 2034. This growth...
0 Комментарии 0 Поделились 3 Просмотры 0 предпросмотр